NEUROTECH USA, INC.
Patent Owner
Stats
- 38 US PATENTS IN FORCE
- 0 US APPLICATIONS PENDING
- Mar 01, 2018 most recent publication
Details
- 38 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 3,733 Total Citation Count
- Mar 10, 1994 Earliest Filing
- 20 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
| Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
- No Recent Publications to Display
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
9265814 Micronized device for the delivery of biologically active molecules and methods of use thereofDec 18, 06Feb 23, 16[A61K, A01N]
9149427 Cell lines that secrete anti-angiogenic antibody-scaffolds and soluble receptors and uses thereofNov 30, 11Oct 06, 15[A61K, C12N, A61L, C07K]
7820195 Micronized device for the delivery of biologically active molecules and methods of use thereofDec 18, 06Oct 26, 10[A61K]
7115257 ARPE-19 as a platform cell line for encapsulated cell-based deliveryApr 06, 00Oct 03, 06[A61K]
6627422 Device containing cell-supporting yarn matrix encapsulated in a semi-permeable membraneDec 21, 00Sep 30, 03[A61F, C12N]
6361771 ARPE-19 as a platform cell line for encapsulated cell-based deliveryApr 05, 00Mar 26, 02[A61K, C12N, A61M]
6303136 Cells or tissue attached to a non-degradable filamentous matrix encapsulated by a semi-permeable membraneApr 12, 99Oct 16, 01[A01N, A61F, C12N]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2015/0150,796 Cryopreserved Implantable Cell Culture Devices and Uses ThereofAbandonedMay 30, 13Jun 04, 15[A61K, A61L]
2015/0024,024 Cell Lines That Produce Prostaglandin F2 Alpha (PGF2A) And Uses ThereofAbandonedApr 21, 10Jan 22, 15[A61K]
2011/0111,008 Use of PEDF in an Encapsulated Cell-Based Delivery SystemAbandonedOct 06, 10May 12, 11[A61K, A61F, C12N]
2010/0272,780 CELL LINES THAT PRODUCE PROSTAGLANDIN F2 ALPHA (PGF2a) AND USES THEREOFAbandonedApr 21, 10Oct 28, 10[A61K, A61F, C12N, A61P]
2009/0269,319 ARPE-19 as a Platform Cell Line for Encapsulated Cell-Based DeliveryAbandonedJul 08, 09Oct 29, 09[A61K, A61P]
2009/0269,389 ARPE-19 as a Platform Cell Line for Encapsulated Cell-Based DeliveryAbandonedJul 07, 09Oct 29, 09[C12N, A61P]
2007/0071,734 ARPE-19 as platform cell line for encapsulated cell-based deliveryAbandonedOct 03, 06Mar 29, 07[A61K, A61F]
6878544 Retinal cell lines with extended life-span and their applicationsExpiredApr 27, 00Apr 12, 05[C12N]
6264941 Compositions for the delivery of biologically active molecules using genetically altered cells contained in biocompatible immunoisolatory capsulesExpiredJan 25, 99Jul 24, 01[A61K]
6183735 Immortalized retinal pigmentary epithelial cell lines and their applicationsExpiredJan 22, 98Feb 06, 01[A61K, C07H, C12N]
5935849 Methods and compositions of growth control for cells encapsulated within bioartificial organsExpiredJul 20, 94Aug 10, 99[C12N]
5858747 Control of cell growth in a bioartificial organ with extracellular matrix coated microcarriersExpiredMay 23, 95Jan 12, 99[C07K]
5853717 Methods and compositions of growth control for cells encapsulated within bioartificial organsExpiredMay 23, 95Dec 29, 98[A01N]
Top Inventors for This Owner
| Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.
